Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Cancer Immunology, Immunotherapy : CII|July 28, 2009
Systemic dysregulation of CEACAM1 in melanoma patientsGal Markel, Rona Ortenberg, Rachel Seidman, et al.
Acta Oncologica (Stockholm, Sweden)|November 19, 2025
Prevalence, molecular characterization, and prognosis of c-Met protein overexpression in a real-world cohort of patients with non-squamous non-small cell lung cancerJair Bar, Mona H Cai, Yookyung Christy Choi, et al.
The Oncologist|March 19, 2022
ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world DataMor Moskovitz, Elizabeth Dudnik, Sivan Shamai, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 3, 2022
Deep inspiratory breath hold assisted by continuous positive airway pressure ventilation for lung stereotactic body radiotherapySarit Appel, Yaacov Richard Lawrence, Jair Bar, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2023
Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancerSameh Daher, Alona Zer, Roi Tschernichovsky, et al.
JTO Clinical and Research Reports|April 22, 2026
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World StudySameh Daher, Walid Shalata, Natali Shirron, et al.
JCO Precision Oncology|November 22, 2024
Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-AnalysisJonathan N Priantti, Yu Fujiwara, Francisco Cezar Aquino de Moraes, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2025
Lurbinectedin for extensive stage - small cell lung cancer (ES-SCLC): real world response patterns and survival outcomesBelal Krayim, Walid Shalata, Jair Bar, et al.
Frontiers in Oncology|June 1, 2022
The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2<sup>nd</sup>/3<sup>rd</sup>-Generation ALK Tyrosine Kinase Inhibitors (TKIs)Ari Raphael, Amir Onn, Liran Holtzman, et al.
The Israel Medical Association Journal : IMAJ|November 6, 2017
Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality StrategySarit Appel, Jeffry Goldstein, Marina Perelman, et al.
Pageof 12